Clinical Trials
90 trialsNeoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
National Institutes of Health Clinical Center (CC)
Mechanisms for Laser-Induced Rejuvenation
Wright State University
CARES
Universitaire Ziekenhuizen KU Leuven
A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
Kupando GmbH
Cryoablation+Ipilimumab+Nivolumab in Melanoma
Massachusetts General Hospital
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
National Institutes of Health Clinical Center (CC)
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Raman Spectroscopy and Skin Cancer
Stony Brook University
iCaRe2
University of Nebraska
Agni-01
Obsidian Therapeutics, Inc.
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, Inc.
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
Alpha Tau Medical LTD.
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Iovance Biotherapeutics, Inc.
ICARUS
University of Thessaly
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
Fred Hutchinson Cancer Center
ctDNA in Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary
MEL
Institute of Health Information and Statistics of the Czech Republic
Pilot Trial of Supplemental Vitamin A and Nicotinamide
Rhode Island Hospital
ADVICE
Filamon LTD
ELEPHAS-04
Mayo Clinic
CEMI-first
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
ANCHOR
Ankyra Therapeutics, Inc
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
The Florida ASCENT Study
University of Florida
MAK
Institute of Oncology Ljubljana
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Institute of Oncology Ljubljana
TIL Therapy in cSCC and MCC
Dana-Farber Cancer Institute
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Mayo Clinic
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
H. Lee Moffitt Cancer Center and Research Institute
IMPACT
Peter MacCallum Cancer Centre, Australia
AI-DSSC
Linkoeping University
ELEPHAS-05
Elephas
ON-5001
OncoNano Medicine, Inc.
Mesur
University of Modena and Reggio Emilia
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
University of Wisconsin, Madison
A Mobile Health Intervention Among Hispanics
Rutgers, The State University of New Jersey
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Emory University
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker
Universitaire Ziekenhuizen KU Leuven
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial
Mayo Clinic
Axitinib + Ipilimumab in Advanced Melanoma
H. Lee Moffitt Cancer Center and Research Institute